Cargando…

Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France

BACKGROUND: We aimed to evaluate the incidence rates between 2010 and 2015 for invasive cervical cancer (ICC), breast cancer (BC), and colorectal cancer (CRC) in people living with HIV (PLWH) in France, and to compare them with those in the French general population. These cancers are targeted by th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rojas Rojas, Teresa, Poizot-Martin, Isabelle, Rey, David, Duvivier, Claudine, Bani-Sadr, Firouzé, Cabie, André, Delobel, Pierre, Jacomet, Christine, Allavena, Clotilde, Ferry, Tristan, Pugliese, Pascal, Valantin, Marc-Antoine, Lamaury, Isabelle, Hustache-Matthieu, Laurent, Fresard, Anne, Houyou, Tamazighth, Huleux, Thomas, Cheret, Antoine, Makinson, Alain, Obry-Roguet, Véronique, Lions, Caroline, Carrieri, Maria Patrizia, Protopopescu, Camelia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8956191/ https://www.ncbi.nlm.nih.gov/pubmed/35333883 http://dx.doi.org/10.1371/journal.pone.0261069

Ejemplares similares

Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015
por: Poizot‐Martin, I., et al.
Publicado: (2020)

Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection
por: Gantner, Pierre, et al.
Publicado: (2019)

Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT’AIDS cohort
por: Lions, C., et al.
Publicado: (2019)

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination
por: Virlogeux, Victor, et al.
Publicado: (2017)

Prevalence and Spectrum of Second Primary Malignancies among People Living with HIV in the French Dat’AIDS Cohort
por: Poizot-Martin, Isabelle, et al.
Publicado: (2022)

Determinants of Second Primary Cancer Type in Survivors of Virus-Related and Non-Virus-Related Cancer Living With HIV in the French Dat’AIDS Cohort
por: Poizot-Martin, Isabelle, et al.
Publicado: (2021)

Potential for Drug-Drug Interactions between Antiretrovirals and HCV Direct Acting Antivirals in a Large Cohort of HIV/HCV Coinfected Patients
por: Poizot-Martin, Isabelle, et al.
Publicado: (2015)

First-line cART regimen impacts the course of CD8(+) T-cell counts in HIV-infected patients that achieve sustained undetectable viral load.
por: Poizot-Martin, Isabelle, et al.
Publicado: (2016)

Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study
por: Cotte, Laurent, et al.
Publicado: (2017)

Efficacy and tolerability of Etravirine in HIV-1 adult patients: Results of a large French prospective cohort
por: Allavena, Clotilde, et al.
Publicado: (2014)

Derivation and internal validation of a mortality risk index for aged people living with HIV: The Dat'AIDS score
por: Hentzien, Maxime, et al.
Publicado: (2018)

Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients
por: Allavena, Clotilde, et al.
Publicado: (2018)

Antiretroviral therapy as a risk factor for chronic kidney disease: Results from traditional regression modeling and causal approach in a large observational study
por: Cuzin, Lise, et al.
Publicado: (2017)

Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study
por: de Boissieu, Paul, et al.
Publicado: (2016)

Comparative Effectiveness of First Antiretroviral Regimens in Clinical Practice Using a Causal Approach
por: Cuzin, Lise, et al.
Publicado: (2015)

CMV+ Serostatus Associates Negatively with CD4:CD8 Ratio Normalization in Controlled HIV-Infected Patients on cART
por: Poizot-Martin, Isabelle, et al.
Publicado: (2016)

Hepatitis C treatment initiation in HIV-HCV coinfected patients
por: Cotte, Laurent, et al.
Publicado: (2016)

Educational intervention and HIV infection: preliminary results
por: Bregigeon, Sylvie, et al.
Publicado: (2010)

Pneumocystis jirovecii Pneumonia and Toxoplasmosis in PWH With HIV-Controlled Disease Treated for Solid Malignancies: A DAT’AIDS Study
por: Pansu, Nathalie, et al.
Publicado: (2022)

Impact of maraviroc on immune restoration in an advanced stage HIV-infected patient
por: Bregigeon, Sylvie, et al.
Publicado: (2010)

HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat’AIDS cohort
por: Hentzien, Maxime, et al.
Publicado: (2019)

Immune Reconstitution Inflammatory Syndrome Associated Kaposi Sarcoma
por: Poizot-Martin, Isabelle, et al.
Publicado: (2022)

High syphilis prevalence and incidence in people living with HIV and Preexposure Prophylaxis users: A retrospective review in the French Dat’AIDS cohort
por: Lemmet, Thomas, et al.
Publicado: (2022)

Risk factors associated with overweight and obesity in HIV-infected people: Aging, behavioral factors but not cART in a cross-sectional study
por: Obry-Roguet, Véronique, et al.
Publicado: (2018)

Too fast to stay on track? Shorter time to first anti-retroviral regimen is not associated with better retention in care in the French Dat’AIDS cohort
por: Cuzin, L., et al.
Publicado: (2019)

Kaposi’s Sarcoma in Virally Suppressed People Living with HIV: An Emerging Condition
por: Palich, Romain, et al.
Publicado: (2021)

Tolerance and durability of abacavir/lamivudine (ABC/3TC)-containing regimens: results from a large prospective French cohort
por: Cuzin, L, et al.
Publicado: (2010)

A Case of Undiagnosed HIV Infection in a 57-Year-Old Woman with Multiple Myeloma: Consequences on Chemotherapy Efficiency and Safety
por: Poizot-Martin, I., et al.
Publicado: (2016)

Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France)
por: Salmon-Ceron, Dominique, et al.
Publicado: (2012)

Raltegravir 1200 mg once daily as maintenance therapy in virologically suppressed HIV-1 infected adults: QDISS open-label trial
por: Hall, Nolwenn, et al.
Publicado: (2022)

The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006-2010
por: Loko, Marc-Arthur, et al.
Publicado: (2010)

Increased liver stiffness is associated with mortality in HIV/HCV coinfected subjects: The French nationwide ANRS CO13 HEPAVIH cohort study
por: Shili-Masmoudi, Sarah, et al.
Publicado: (2019)

Impact of etravirine use on hospitalization rates among highly pre-treated failing HIV-1 infected individuals between 2005 and 2011
por: Lacombe, Jean-Marc, et al.
Publicado: (2014)

Impact of etravirine on hospitalization rate between 2005 and 2011 among heavily treated HIV-1-infected individuals on failing regimens
por: Potard, Valérie, et al.
Publicado: (2018)

Acceptability and confidence in antiretroviral generics of physicians and HIV-infected patients in France
por: Allavena, Clotilde, et al.
Publicado: (2014)

Changes in immune activation in the T Cell compartments of HIV HCV coinfected patients during PEG IFN RBV treatment
por: Menard, Amélie, et al.
Publicado: (2012)

Perception of Antiretroviral Generic Medicines: One-Day Survey of HIV-Infected Patients and Their Physicians in France
por: Jacomet, Christine, et al.
Publicado: (2015)

A Single HIV-1 Cluster and a Skewed Immune Homeostasis Drive the Early Spread of HIV among Resting CD4+ Cell Subsets within One Month Post-Infection
por: Bacchus, Charline, et al.
Publicado: (2013)

Initial assemblage characteristics determine the functional dynamics of flower‐strip plant communities
por: Gardarin, Antoine, et al.
Publicado: (2022)

Therapeutic Perspectives in the Systemic Treatment of Kaposi’s Sarcoma
por: Valantin, Marc-Antoine, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m3fqa2im30cou2aqb336qp20fs